Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer

Archive ouverte

Burgassi, Fiamma | Paillaud, Elena | Poisson, Johanne | Bousquet, Guilhem | Pamoukdjian, Frédéric

Edité par CCSD ; MDPI -

International audience. The prognostic value of the CRP to albumin ratio (CAR) among older adults with cancer is not known. Six hundred and three older outpatients with cancer and undergoing geriatric assessment before therapeutic decisions were prospectively recruited from the PF-EC cohort study. Serum albumin levels, serum CRP levels and the CAR were prospectively recorded at baseline, and at each consultation thereafter, as follows: 1, 3, 6, 9, 12, 18, 24 and 36 months. Frailty was defined as a G8-index ≤ 14. The primary endpoint was longitudinal variation in the CAR during the study follow-up. Two clusters in the longitudinal trajectories of the CAR were identified, one favourable, with lower values and better overall survival (cluster A), and the second with higher values and less favourable overall survival (cluster B). The median CAR [95% CI] for clusters A and B were respectively: 0.17 [0.04–0.48] and 0.26 [0.04–0.79] at baseline (p = 0.01), and 0.18 [0.02–3.17] and 0.76 [0.03–6.87] during the study follow-up (p < 0.0001). Cluster B was associated with the frailest patients with metastatic disease, mainly driven by a high CRP level at baseline, and low albumin during the study follow-up. Our study results suggest that the most risk-prone patients have a cancer-cachexia trajectory.

Suggestions

Du même auteur

Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment

Archive ouverte | Couderc, Anne-Laure | CCSD

International audience. This study will address the prevalence of pre-therapeutic sarcopenia (PS) and its clinical impact during cancer treatment among adult cancer patients ≥ 18 years of age. A meta-analysis (MA) w...

Safety and efficacy of immunotherapy according to the age threshold of 80 years

Archive ouverte | Mebarki, Soraya | CCSD

International audience. Background: To compare safety and efficacy of ICIs among patients<80 and those ≥80 years of age.Methods: A single-center retrospective observational cohort study comparing patients<80 and ≥80...

How to optimize cancer treatment in older patients: an overview of available geriatric tools

Archive ouverte | Pamoukdjian, Frédéric | CCSD

International audience. Cancer is a disease of older people, but this age group has often been excluded from clinical trials of cancer, which leads to poor transportability of standardized treatments in older cancer...

Chargement des enrichissements...